← Browse by Condition
Medical Condition
hepatocellular carcinoma
Total Trials
54
Recruiting Now
54
Trial Phases
Phase 2, Phase 1, Phase 2, Phase 1
NCT06406634 Phase 2
Recruiting
Cadonilimab in Combination With Lenvatinib and Hepatic Arterial Infusion Chemotherapy (HAIC) for the Treatment of Unresectable Hepatocellular Carcinoma
Enrollment
30 pts
Location
China
Sponsor
Hunan Cancer Hospital
NCT05992584 Phase 2
Recruiting
Lenvatinib, Sintilimab Plus SIRT for Unresectable HCC
Enrollment
30 pts
Location
China
Sponsor
Second Affiliated Hospital of ...
NCT06950827
Recruiting
Textbook Outcomes of Right Hemihepatectomy in Patients With Hepatocellular Carcinoma
Enrollment
400 pts
Location
China
Sponsor
West China Hospital
NCT06880523 Phase 2
Recruiting
STRIDE (Durvalumab + Tremelimumab) With Lenvatinib vs STRIDE Alone in Unresectable Hepatocellular Carcinoma
Enrollment
140 pts
Location
Canada
Sponsor
Canadian Cancer Trials Group
NCT03482102 Phase 2
Recruiting
Durvalumab (MEDI4736) and Tremelimumab and Radiation Therapy in Hepatocellular Carcinoma and Biliary Tract Cancer
Enrollment
70 pts
Location
United States
Sponsor
Massachusetts General Hospital
NCT06218420 Phase 2
Recruiting
Evaluation of Stereotactic Body Radiotherapy as a Bridge Therapy for Hepatocellular Carcinoma Patients Enlisted for Liver Transplantation
Enrollment
139 pts
Location
France
Sponsor
Assistance Publique - Hôpitaux...
NCT04864054 Phase 1, Phase 2
Recruiting
T-Cell Therapy (ECT204) in Adults With Advanced HCC
Enrollment
20 pts
Location
United States, Taiwa...
Sponsor
Eureka Therapeutics Inc.
NCT06795022 Phase 1, Phase 2
Recruiting
First in Human Study to Evaluate AZD9793 in Participants With Advanced or Metastatic Solid Tumours
Enrollment
304 pts
Location
United States, China...
Sponsor
AstraZeneca
NCT06530251 Phase 1, Phase 2
Recruiting
A Study of AK112 in Patients With Advanced Hepatocellular Carcinoma (HCC)
Enrollment
280 pts
Location
China
Sponsor
Akeso
NCT06326502 Phase 1
Recruiting
A Safety and Efficacy Study of Multiple Tyrosine Kinase Inhibitor Drug (ETN101) in Advanced Hepatocellular Carcinoma
Enrollment
50 pts
Location
South Korea
Sponsor
Etnova Therapeutics Corp.
NCT06544629
Recruiting
Imjudo & Imfinzi PMS
Enrollment
246 pts
Location
South Korea
Sponsor
AstraZeneca
NCT06389422 Phase 2
Recruiting
Phase II Study of Moderate-dose Hypofractionated RT Combined With Pembrolizumab for HCC With Diffuse Tumor Thrombosis
Enrollment
30 pts
Location
China
Sponsor
Cancer Institute and Hospital,...
NCT06179602
Recruiting
Prospective Cohort Study on Thermal Ablation of Malignant Liver Tumors
Enrollment
1,500 pts
Location
Netherlands
Sponsor
Leiden University Medical Cent...
NCT05276037
Recruiting
Value of Negative 18FDG PET/CT in Milan Out, Up-to-seven in, HCC Transplant Candidates
Enrollment
350 pts
Location
Belgium
Sponsor
University of Liege
NCT06375486 Phase 2
Recruiting
Ivonescimab Combined With HAIC for the Treatment of Unresectable Hepatocellular Carcinoma（uHCC）.
Enrollment
30 pts
Location
China
Sponsor
Tianjin Medical University Can...
NCT06740370
Recruiting
TACE Combined With Lenvatinib and PD-1 Inhibitor for Ruptured Hepatocellular Carcinoma
Enrollment
32 pts
Location
China
Sponsor
Sun Yat-sen University
NCT05409482
Recruiting
A Real-world Study of Camrelizumab Combined With Apatinib Mesylate in Unresectable Hepatocellular Carcinoma
Enrollment
300 pts
Location
China
Sponsor
Meng Chao Hepatobiliary Hospit...
NCT06549829
Recruiting
The Effect of Nutrition-optimized Prehabilitation on Perioperative Intervention in Primary Hepatocellular Carcinoma
Enrollment
200 pts
Location
China
Sponsor
Second Affiliated Hospital, Sc...
NCT06478927
Recruiting
Backline Treatment of Advanced Hepatocellular Carcinoma With Palbociclib
Enrollment
22 pts
Location
China
Sponsor
Henan Cancer Hospital
NCT06508307 Phase 1
Recruiting
A Phase I Clinical Study of Intratumoral Injection Oncolytic Vaccinia Virus GC001 in Patient With Advanced Solid Tumors
Enrollment
21 pts
Location
China
Sponsor
GONGCHU Biotechnology Co., Ltd
NCT06679985 Phase 2
Recruiting
A Trial of Casdozokitug in Combination With Toripalimab Plus Bevacizumab in Participants With Unresectable and/or Locally Advanced or Metastatic Hepatocellular Carcinoma
Enrollment
72 pts
Location
United States, Austr...
Sponsor
Coherus Oncology, Inc.
NCT04512833
Recruiting
CyberKnife Stereotactic Body Radiation Therapy for Small Hepatocellular Carcinoma Patients With Decompensated Cirrhosis
Enrollment
60 pts
Location
China
Sponsor
Beijing 302 Hospital
NCT06887348
Recruiting
A Study to Assess the Long-term Safety Outcomes in Patients Previously Treated With RP1, RP2, or RP3
Enrollment
50 pts
Location
United States, Austr...
Sponsor
Replimune Inc.
NCT05223816 Phase 2
Recruiting
An Open-Label, Multiple-Center, Phase IIa/IIb Clinical Trial to Evaluate the Efficacy, Safety and Tolerability of VG161 as Monotherapy and in Combination With Nivolumab for Treatment of Patients With Hepatocellular Carcinoma or Intrahepatic Cholangiocarcinoma
Enrollment
97 pts
Location
United States
Sponsor
Virogin Biotech Canada Ltd
NCT05440708 Phase 1, Phase 2
Recruiting
A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma
Enrollment
178 pts
Location
United States
Sponsor
Tvardi Therapeutics, Incorpora...
NCT05954897 Phase 2
Recruiting
Lenvatinib, Tislelizumab Combined With RALOX Regimen HAIC in Advanced Hepatocellular Carcinoma
Enrollment
29 pts
Location
China
Sponsor
Guangdong Provincial People's ...
NCT06260943
Recruiting
Targeted Navigation in Hepatocellular Carcinoma (HCC)
Enrollment
100 pts
Location
United States
Sponsor
University of Miami
NCT06475118
Recruiting
Comparison of Serum Myokine Dosages and Imaging Methods in the Evaluation of Sarcopenia in Patients With Hepatocellular Carcinoma
Enrollment
139 pts
Location
France
Sponsor
CHU de Reims
NCT06114082 Phase 2
Recruiting
TACE Using Idarubicin Versus Doxorubicin Chemoemulsion in Patients with Hepatocellular Carcinoma
Enrollment
128 pts
Location
South Korea
Sponsor
Seoul National University Hosp...
NCT05394259 Phase 1
Recruiting
A Pilot Study to Assess the Clinical Utility of PYLARIFY PET-CT for Detecting Metastasis in Pancreatic Cancer, Hepatocellular Carcinoma and Breast Cancer
Enrollment
36 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
NCT05520788
Recruiting
Ambispective Cohort Study of Precision Medicine for Primary Hepatobiliary Cancer Based on Next-generation Sequencing
Enrollment
200 pts
Location
China
Sponsor
Tongji Hospital
NCT06577272
Recruiting
Title of Manuscript: Development and Internal-external Validation of a Comprehensive Model for Predicting Risk of Post-RFA Recurrence in HCC Patients
Enrollment
6,000 pts
Location
China
Sponsor
Tian'an Jiang
NCT05323201 Phase 1, Phase 2
Recruiting
Study Of B7H3 CAR-T Cells in Treating Advanced Liver Cancer
Enrollment
15 pts
Location
China
Sponsor
The Affiliated Hospital of Xuz...
NCT05803928 Phase 1
Recruiting
Ablation in Combination With Lenvatinib and Anti-PD-1 Antibodies
Enrollment
70 pts
Location
China
Sponsor
Hua Li
NCT06434753 Phase 3
Recruiting
Zinc Supplementation to Improve Prognosis in Patients With Compensated Advanced Chronic Liver Disease.
Enrollment
300 pts
Location
Spain
Sponsor
Hospital Universitari Vall d'H...
NCT06201065 Phase 3
Recruiting
FOLFOX-HAIC Plus Lenvatinib and Toripalimab vs. FOLFOX-HAIC Plus Lenvatinib for Advanced Hepatocellular Carcinoma: a Randomized Controlled and Double-blind Trial
Enrollment
200 pts
Location
China
Sponsor
Sun Yat-sen University
NCT04282044 Phase 1
Recruiting
Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies
Enrollment
60 pts
Location
United States
Sponsor
BioEclipse Therapeutics
NCT04792801
Recruiting
PET TDM FDG-Choline as a Decision-making Tool for Routine Care on the Liver Transplant List for HCC
Enrollment
100 pts
Location
France
Sponsor
University Hospital, Lille
NCT06694636
Recruiting
Intravascular Radiofrequency Ablation of Sympathetic Nerves for the Treatment of Hepatocellular Carcinoma
Enrollment
5 pts
Location
China
Sponsor
Zhongda Hospital
NCT06034977 Phase 2
Recruiting
Phase 2 Study of ADI-PEG 20 Plus Lenvatinib Treatment in Subjects With Unresectable Hepatocellular Carcinoma
Enrollment
120 pts
Location
Taiwan
Sponsor
Chang Gung Memorial Hospital
NCT06090656 Phase 2
Recruiting
Bevacizumab in Combination With Sintilimab Versus Transcatheter Arterial Chemoembolization for the Treatment of Intermediate Stage Hepatocellular Carcinoma (Beyond Up-To-Seven Criteria)
Enrollment
88 pts
Location
China
Sponsor
Sun Yat-sen University
NCT03686709
Recruiting
Y90 Radioembolization Dose Delivery and Radiation Exposure Assessment
Enrollment
20 pts
Location
United States
Sponsor
University of Tennessee
NCT06339424 Phase 2
Recruiting
Atezolizumab and Bevacizumab With Photon Radiotherapy for Unresectable Hepatocellular Carcinoma
Enrollment
45 pts
Location
Taiwan
Sponsor
Chang Gung Memorial Hospital
NCT07178093
Recruiting
Effects of Antrodia Cinnamomea on the Hepatoma Patients After Transcatheter Hepatic Artery Chemoembolization
Enrollment
60 pts
Location
Taiwan
Sponsor
Taichung Tzu Chi Hospital
NCT07485114
Recruiting
Association Between Galectin-3 Levels and Outcomes in Patients With Renal Cell Carcinoma, Transitional Cell Carcinoma , Non Small Cell Lung Cancer, and Hepatocellular Carcinoma, Treated With PD-1/PDL-1 Inhibitors
Enrollment
300 pts
Location
Israel
Sponsor
Daniel Keizman
NCT05613478 Phase 3
Recruiting
Camrelizumab Combined With Apatinib Mesylate and TACE in the Perioperative Treatment of Hepatocellular Carcinoma
Enrollment
130 pts
Location
China
Sponsor
The First Affiliated Hospital ...
NCT04145141
Recruiting
National Translational Science Network of Precision-based Immunotherapy for Primary Liver Cancer
Enrollment
500 pts
Location
United States
Sponsor
National Cancer Institute (NCI...
NCT05072041
Recruiting
Safety and Efficacy of Degradable Microsphere in Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma
Enrollment
150 pts
Location
South Korea
Sponsor
Next Biomedical Co., Ltd.
NCT04340986
Recruiting
Cohort of Patients With Hepatocellular Carcinoma or Cholangiocarcinoma
Enrollment
1,250 pts
Location
France
Sponsor
Assistance Publique - Hôpitaux...
NCT05482516 Phase 3
Recruiting
Evaluating Novel Therapies in ctDNA Positive GI Cancers
Enrollment
20 pts
Location
United States
Sponsor
Georgetown University
NCT06581315
Recruiting
Postoperative Adjuvant Therapy of Donafenib for Hepatocellular Carcinoma
Enrollment
204 pts
Location
China
Sponsor
Sun Yat-Sen Memorial Hospital ...
NCT06313190 Phase 2
Recruiting
Combination of SBRT and Immunotherapy in Small Hepatocellular Carcinoma (HSBRT2402)
Enrollment
140 pts
Location
China
Sponsor
Sun Yat-sen University
NCT06204835 Phase 1
Recruiting
ITGA6 Targeting NIR-II Fluorescence Image Guided Surgery
Enrollment
90 pts
Location
China
Sponsor
Institute of Automation, Chine...
NCT06632717 Phase 2
Recruiting
Hepatic Arterial Infusion Chemotherapy With Lipiodol Embolization in Advanced Hepatocellular Carcinoma
Enrollment
24 pts
Location
Taiwan
Sponsor
National Taiwan University Hos...